Halozyme Therapeutics
HALOHalozyme Therapeutics is a U.S. biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships. The company was founded in 1998 and went public in 2004. Halozyme is headquartered …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Halozyme Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 8/13/2025 | Sell | Torley, Helen | PRESIDENT AND CEO | $64.5 | $1,286,350 |
| 8/12/2025 | Sell | Torley, Helen | PRESIDENT AND CEO | $63.6 | $1,270,121 |
| 8/11/2025 | Sell | Torley, Helen | PRESIDENT AND CEO | $63.3 | $1,260,917 |
| 7/10/2025 | Sell | Torley, Helen | PRESIDENT AND CEO | $57.2 | $1,148,617 |
| 7/9/2025 | Sell | Torley, Helen | PRESIDENT AND CEO | $56.8 | $1,128,655 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)